Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.35 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.34 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.34 |
| ▸ | BMP1 | P13497 | 1/20 | 0.33 |
| ▸ | GGH | Q92820 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5832633 | 0.98 | KMT2A (0.41) | KMT2AALOX15BLMPMP22L3MBTL1 | |
| SCHEMBL2244574 | 0.85 | KMT2A (0.41) | KMT2AALOX15BLMPMP22L3MBTL1 | |
| SCHEMBL2247878 | 0.82 | KMT2A (0.45) | KMT2AALOX15BLMPMP22L3MBTL1 | |
| SCHEMBL20299077 | 0.82 | KMT2A (0.45) | KMT2AALOX15BLMPMP22L3MBTL1 | |
| Hydrochloric Acid SCHEMBL28131080 | 0.79 | L3MBTL1 (0.39) | KMT2AALOX15BLMPMP22L3MBTL1 | |
| SCHEMBL27967037 | 0.77 | KMT2A (0.40) | KMT2AALOX15BLMPMP22L3MBTL1 | |
| SCHEMBL2247130 | 0.76 | KMT2A (0.48) | KMT2AL3MBTL1MMP2MMP9CA2 | |
| Hydrochloric Acid SCHEMBL23834101 | 0.74 | KMT2A (0.48) | KMT2AALOX15BLMPMP22L3MBTL1 | |
| Hydrochloric Acid SCHEMBL22978412 | 0.74 | KMT2A (0.48) | KMT2AALOX15BLMPMP22L3MBTL1 | |
| Hydrochloric Acid SCHEMBL5408064 | 0.74 | KMT2A (0.48) | KMT2AALOX15BLMPMP22L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3485920-B1 | COATING METHOD FOR A FOLDED BALLOON | BRAUN MELSUNGEN AG (DE) | 2020-05-20 | — | — | EP | claimed |
| EP-3150236-B1 | COATING METHOD FOR A FOLDED BALLOON | BRAUN MELSUNGEN AG (DE) | 2018-12-26 | — | — | EP | claimed |
| EP-1981559-B1 | COATING METHOD FOR A FOLDED BALLOON | BRAUN MELSUNGEN AG (DE) | 2016-11-23 | — | — | EP | claimed |
| EP-0711158-B2 | METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT | US GOV HEALTH & HUMAN SERV (US) | 2008-07-23 | — | — | EP | claimed |
| EP-3081196-B1 | INTEGRATED STENT RETRIEVAL LOOP ADAPTED FOR SNARE REMOVAL AND/OR OPTIMIZED PURSE STRINGING | BOSTON SCIENT SCIMED INC (US) | 2018-04-18 | — | — | EP | disclosed |
| US-9694177-B2 | Electrically controlled ion transport device | OBOE IPR AB (SE) | 2017-07-04 | — | — | US | disclosed |
| EP-3081196-A1 | INTEGRATED STENT RETRIEVAL LOOP ADAPTED FOR SNARE REMOVAL AND/OR OPTIMIZED PURSE STRINGING | Boston Scientific Scimed, Inc. (US) | 2016-10-19 | — | — | EP | disclosed |
| EP-2480179-B1 | INTEGRATED STENT RETRIEVAL LOOP ADAPTED FOR SNARE REMOVAL AND/OR OPTIMIZED PURSE STRINGING | BOSTON SCIENT SCIMED INC (US) | 2016-08-17 | — | — | EP | disclosed |
| US-20150209299-A1 | DRUG-ELUTING MEDICAL DEVICES | THE JOHNS HOPKINS UNIVERSITY | 2015-07-30 | — | — | US | disclosed |
| US-8815275-B2 | Coatings for medical devices comprising a therapeutic agent and a metallic material | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-8728150-B2 | Medical device loaded with formulation for targeted delivery of biologically active material/s and method of manufacture thereof | MERIL LIFE SCIENCES PRIVATE LIMITED (IN) | 2014-05-20 | — | — | US | disclosed |
| US-20140135386-A1 | METHOD FOR TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT | The Government of the United States as Represented by the Secretary, Dept. of Health & Human Service (US) | 2014-05-15 | — | — | US | disclosed |
| US-20070055366-A1 | Stent with web-inducing nodes for increased surface area | BOSTON SCIENTIFIC SCIMED, INC. | 2007-03-08 | — | — | US | disclosed |
| US-20070055352-A1 | Stent with pockets for containing a therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. | 2007-03-08 | — | — | US | disclosed |
| US-20060251824-A1 | Coating of medical devices with solids | BOSTON SCIENTIFIC SCIMED, INC. | 2006-11-09 | — | — | US | disclosed |
| US-20060089709-A1 | Medical implant with average surface charge density | BOSTON SCIENTIFIC SCIMED, INC. | 2006-04-27 | — | — | US | disclosed |
| US-20060034884-A1 | Coated medical device having an increased coating surface area | BOSTON SCIENTIFIC SCIMED, INC. | 2006-02-16 | — | — | US | disclosed |
| US-20060035011-A1 | Method of cryogenically coating a device | BOSTON SCIENTIFIC SCIMED, INC. | 2006-02-16 | — | — | US | disclosed |
| US-20050196614-A1 | Apparatus and method for coating objects using an optical system | BOSTON SCIENTIFIC SCIMED, INC. | 2005-09-08 | — | — | US | disclosed |
| US-20050113903-A1 | Medical device for delivering biologically active material | SCIMED LIFE SYSTEMS, INC. | 2005-05-26 | — | — | US | disclosed |